dynatronics.com (DYNT): Debts to Book Capitalization

Brandmark of dynatronics.com (DYNT)

The share of financial debt in the balance sheet capitalization of Dynatronics Corporation (DYNT) is declining, which correlates with the moderate cyclicality of demand for rehabilitation equipment. 0.00 becomes the new value for this metric amid the abandonment of low-margin distribution and strict cost controls. The current strategy of Dynatronics Corporation (DYNT) is based on the gradual closure of orthopedic lines and the return of capital to shareholders through asset sales.

DYNT - Dynatronics Debts to Net Assets over the range 07/04/2022 - 08/04/2024
Original product of dynatronics.com

Dynatronics Corporation (DYNT) supplies specialized rehabilitation equipment to clinics under strict FDA supervision. The debt-to-equity ratio trend compares total liabilities against the market value of net assets. This indicator determines the degree of financial stability and the risk of default during market volatility. Reducing the debt load is critical to protecting the business from price competition from local suppliers. Analysis of the curve allows for an assessment of capital management efficiency amid the erosion of competitive advantages.

Competitors of Dynatronics Corporation

BSX: Debts to Book Capitalization|Debts to Book Value edwards.com EW|RMD: Debts to Book Capitalization|PODD - Debt to Book Value|Zimmer Biomet - Debts to Book Capitalization|CooperSurgical (COO) - Debts to Net Assets|ALGN (Align Technology, Inc.) - Debts to Book Capitalization|Debts to Book Capitalization GMED|Debt to Book Capitalization Ratio TransMedics Organ Care System (TMDX)|Debt to Book Capitalization Ratio Alphatec Holdings (ATEC)|Debts to Book Capitalization AORT|ENOV - Debts to Net Assets|Debt to Book Value Integra LifeSciences|ESTA - Debts to Book Capitalization Ratio|Debts to Book Capitalization BBNX|IRADIMED Corp (IRMD) - Debts to Book Value|Debts to Book Capitalization Embecta Inc. (EMBC)|Debt to Book Value Ratio Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Debt to Book Value|Debt to Net Assets Ratio SIBN (si-bone.com)|Orthofix - Debt to Book Capitalization Ratio|Debt to Book Value Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Debts to Book Capitalization|TMCI - Debts to Book Value|Debts to Book Capitalization Strata Critical Medical Inc|carlsmed.com (CARL) - Debt to Book Value Ratio|RXST: Debts to Book Capitalization|Debts to Net Assets ClearPoint|Debts to Book Capitalization STXS (Stereotaxis Corp)|Debt to Book Value Neuronetics, Inc (STIM)|Debts to Book Capitalization SGHT (Sight Sciences, Inc.)|Orchestra BioMed Inc. - Debts to Book Capitalization|ANIK - Debt to Book Capitalization Ratio|InspireMD Inc (NSPR) - Debt to Book Capitalization Ratio|Debt to Book Value zhjmedical.com ZJYL|Vivani Medical (VANI) - Debt to Net Assets Ratio|Debts to Book Capitalization XTNT (Xtant Medical Holdings, Inc.)|Debts to Book Value NMTC|MODD: Debt to Book Capitalization Ratio|Debt to Net Assets Myomo Inc. MYO|Debt to Book Value COCH (Envoy Medical, Inc)|Debts to Book Capitalization Vivos Therapeutics Inc VVOS|Debts to Book Capitalization NVNO (enVVeno Medical)|SINT: Debts to Net Assets|Debt to Book Capitalization Ratio Tenon Medical (TNON)|LFWD (ReWalk Robotics) - Debts to Book Capitalization Ratio|Debt to Book Capitalization Ratio AMIX|Debt to Book Value INVO Fertility Corp|Bone Biologics - Debts to Book Capitalization|Debts to Book Value AXNX (axonics.com)|BIOL - Debt to Book Capitalization Ratio|FNA - Debt to Book Value Ratio|Debt to Book Value INVO Bio INVO